Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Riedl

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
BMC Cancer|June 17, 2017
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort studyJakob Michael Riedl, Florian Posch, Angelika Bezan, et al.
Nature Immunology|July 15, 2025
Migrating immune cells globally coordinate protrusive forcesPatricia Reis-Rodrigues, Mario J Avellaneda, Nikola Canigova, et al.
Cancers|May 8, 2020
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer PatientsEva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, et al.
Developmental Cell|December 17, 2021
WASp triggers mechanosensitive actin patches to facilitate immune cell migration in dense tissuesFlorian Gaertner, Patricia Reis-Rodrigues, Ingrid de Vries, et al.
Scientific Reports|December 16, 2023
Sustainable manufacturing through application of reconfigurable and intelligent systems in production processes: a system perspectiveMarco Todescato, Orjola Braholli, Dmitry Chaltsev, et al.
Therapeutic Advances in Medical Oncology|April 22, 2020
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional studyJakob Michael Riedl, Florian Posch, Gerald Prager, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
BMC Cancer|June 17, 2017
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort studyJakob Michael Riedl, Florian Posch, Angelika Bezan, et al.
Nature Immunology|July 15, 2025
Migrating immune cells globally coordinate protrusive forcesPatricia Reis-Rodrigues, Mario J Avellaneda, Nikola Canigova, et al.
Cancers|May 8, 2020
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer PatientsEva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, et al.
Developmental Cell|December 17, 2021
WASp triggers mechanosensitive actin patches to facilitate immune cell migration in dense tissuesFlorian Gaertner, Patricia Reis-Rodrigues, Ingrid de Vries, et al.
Scientific Reports|December 16, 2023
Sustainable manufacturing through application of reconfigurable and intelligent systems in production processes: a system perspectiveMarco Todescato, Orjola Braholli, Dmitry Chaltsev, et al.
Therapeutic Advances in Medical Oncology|April 22, 2020
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional studyJakob Michael Riedl, Florian Posch, Gerald Prager, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Pageof 2